PostEra was founded by Aaron Morris, Alpha Lee, Matthew Robinson in 2019.

Who are PostEra's investors?

PostEra's investors include Breyer Capital, HOF Capital, Lifeforce Capital, Metaplanet, Pioneer, Y Combinator, ACE & Company, I2BF Global Ventures and 1 more.

How much funding has PostEra raised?

PostEra has disclosed $26.1M raised across 1 of its 2 known rounds.

Where is PostEra headquartered?

PostEra is headquartered in Boston, US.

PostEra

YC W20

Boston, US · Founded 2019 · Delaware corporation · 40 employees · 9 known investors

Find your way into PostEra

Paths you didn't know you had: your email and LinkedIn already hold routes to the PostEra team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies. The platform combines machine learning, medicinal chemistry, and software engineering to improve the drug development process.

AI & Machine Learning Biotech Deep Tech Healthtech Medical Devices AI-powered Drug Discovery Machine Learning COVID-19United States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W20)

PostEra was founded in 2019 by Aaron Morris, Alpha Lee, and Matthew Robinson.

Aaron Morris CEO & Co-FounderAaron Morris is founder and CEO of PostEra, which applies artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies.

Alpha LeeCo-Founder & Chief Scientific Officer

Matthew RobinsonFounder

Matt RobinsonFounder

Rachael SpringerExecutive Assistant

Adam MorraLead, Machine Learning

Milan CvitkovicML Researcherformer

Ruby PaiML Researcherformer

Jin PanSoftware Engineerformer

Emily RipkaFull Stack Developerformer

Sasha ValleChief of Staffformer

Mihir TrivediSoftware Engineerformer

Investors · 9

Breyer Capitallisted by Breyer CapitalAustin · $500K – $10M

How we know: Breyer Capital's portfolio page · the VCSheet dataset · Not right? Tell us

HOF Capitallisted by HOF CapitalNew York · $500K – $10M

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Lifeforce Capitallisted by Lifeforce CapitalChevy Chase · $500K – $5M

How we know: Lifeforce Capital's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Metaplanetlisted by MetaplanetTallinn · $500K – $10M

How we know: Metaplanet's portfolio page · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Pioneerlisted by PioneerToronto, Ontario

How we know: Pioneer's portfolio page · Y Combinator's founder network · pioneerfund.vc · open dataset · 5k.vc investor directory · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

ACE & CompanyreportedGenevavia Sherif El Halwagy · inferred

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

I2BF Global VenturesreportedNew York · $500K – $10M

How we know: Y Combinator's founder network · open dataset · 5k.vc investor directory · Not right? Tell us

Sam Altmanreported

How we know: Y Combinator's founder network · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$26.1M disclosed across 1 of 2 rounds · 2021–2025

▶$26.1MraisedJan 2022 · 21 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Matthew RobinsonExecutive Officer, Director
Alpha LeeExecutive Officer, Director
Aaron MorrisExecutive Officer, Director

Offering amount: $27.5M
Amount sold: $26.1M
First sale: Dec 2021
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Images

Related companies · 4

PreDxion BioPreDxion Bio develops rapid diagnostic tests using saliva samples and a scalable semiconductor-based platform, initially targeting SARS-CoV-2 detection for asymptomatic and presymptomatic individuals, with broader applications in monitoring immune response markers in critically ill patients and predicting complications from cell therapies.

ScoutScout develops portable molecular diagnostic testing devices that deliver lab-grade accuracy in under 30 minutes for point-of-care use. The platform enables healthcare providers to test and treat patients in real-time without requiring lab infrastructure or specialized training.

ProthenaProthena is a clinical-stage biotechnology company developing investigational therapies for neurodegenerative and rare peripheral amyloid diseases by targeting misfolded proteins. The company leverages its scientific legacy from Athena Neurosciences and collaborates with academic and industry partners to advance its pipeline of novel therapeutic candidates.

Ideaya BiosciencesIDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers. Its lead candidate, darovasertib, is in late-stage trials for uveal melanoma, with a pipeline spanning PKC inhibition, ADC+DDR combinations, the MTAP pathway, and KAT6/7 inhibition.

Companies working in the same space as PostEra.

Legal entities · 1

corporate structure

PostEra Inc.

In the news

PostEra establishes $260M strategic AI Lab partnership with Pfizer and closes $24M in Series A financing - PostErapostera.ai

Frequently asked questions

What does PostEra do?: Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies. The platform combines machine learning, medicinal chemistry, and software engineering to improve the drug development process.
Who founded PostEra?: PostEra was founded by Aaron Morris, Alpha Lee, Matthew Robinson in 2019.
Who are PostEra's investors?: PostEra's investors include Breyer Capital, HOF Capital, Lifeforce Capital, Metaplanet, Pioneer, Y Combinator, ACE & Company, I2BF Global Ventures and 1 more.
How much funding has PostEra raised?: PostEra has disclosed $26.1M raised across 1 of its 2 known rounds.
Where is PostEra headquartered?: PostEra is headquartered in Boston, US.